Blood Culture Tests Market Worth 4,768.9 Million USD by 2021

1
Blood Culture Tests Market Worth 4,768.9 Million
USD by 2021
www.MarketsandMarkets.com
2
According to a new market research report "Blood
Culture Tests Market by Method (Automated,
Manual), Product (Consumables, Instrument),
Technology (PCR, Microarray, Proteomic),
Application (Bacteremia, Fungemia) End User
(Hopsital Laboratories, Reference Laboratories) -
Global Forecast to 2021", published by
MarketsandMarkets, The global market is projected
to reach USD 4,768.9 Million by 2021 from USD
3,252.6 Million in 2016, at a CAGR of 8.0.
3
Browse 300 market data Tables and 50 Figures
spread through 249 Pages and in-depth TOC on
"Blood Culture Tests Market http//www.marketsan
dmarkets.com/Market-Reports/blood-culture-test-mar
ket-159606753.html Early buyers will receive 10
customization on this report.  Factors such as
rapidly rising aging population, increase in
product approvals and launches, high incidence of
bloodstream infections, high prevelance of
infectious diseases, and increase in demand for
rapid diagnostic techniques are driving the
growth of the Blood Culture Tests Market during
the forecast period. In this report, the Blood
Culture Tests Market is segmented on the basis of
method, product, technology, application, end
user, and region. Based on end user, the Blood
Culture Tests Market is segmented into hospital
laboratories, reference laboratories, academic
research laboratories, and other laboratories
(pathology laboratories, bacteriological
laboratories, physician office laboratories
(POLs), and independent research laboratories).
The reference laboratories segment is expected to
grow at the highest CAGR during the forecast
period.
4
The high growth of this segment is attributed to
the increasing outsourcing of blood culture tests
by hospitals to reference laboratories, as they
can perform a large volume of tests and are
equipped with advanced diagnostic techniques that
provide blood culture tests with a quick
turnaround time. Geographically, the Blood
Culture Tests Market is segmented into North
America, Europe, Asia, and the Rest of the World
(RoW). In 2016, North America is expected to
account for the largest share of the Blood
Culture Tests Market. However, the Asian market
is expected to grow at the highest CAGR. Growth
in the Asian market can be attributed to the high
incidence of sepsis and government initiatives to
increase awareness on the disease, increasing
demand for effective diagnostic techniques,
rising awareness about early disease diagnosis,
increasing adoption of advanced technologies,
rapid rise in geriatric population, and growing
regulatory approvals availability of blood
culture test products in this region. A
complete brochure for this research is available
_at_ http//www.marketsandmarkets.com/pdfdownload.asp
?id159606753
5
On the basis of end users, the blood culture
tests market is segmented into hospital
laboratories, reference laboratories, academic
research laboratories, and other laboratories
(pathology laboratories, bacteriological
laboratories, physician office laboratories
(POLs), and independent research laboratories).
The reference laboratories segment is expected to
grow at the highest CAGR during the forecast
period. The increasing outsourcing of blood
culture tests by hospitals to reference
laboratories, as they are equipped with advanced
diagnostic techniques that provide blood culture
tests with a quick turnaround time, is the
primary growth driver for this market
segment. The Blood Culture Tests Market is highly
competitive, with prominent players such as
Becton, Dickinson and Company (U.S.), bioMérieux
SA (France), and Thermo Fisher Scientific, Inc.
(U.S.). Some of the other players in this market
include Cepheid, Inc. (U.S.), Nanosphere, Inc.
(U.S.), IRIDICA (U.S.), Beckman Coulter (U.S.),
Bruker Corporation (U.S.), and T2 Biosystems
(U.S.).
6
Browse Related Reports  Microbiology
Testing/Clinical Microbiology Market by
Microbiology Application (Pharmaceutical,
Clinical, Manufacturing, Energy), Clinical
Application (Respiratory Diseases, STD, UTI),
Product (instruments, Analyzers, Consumables) -
Global Forecasts to 2021. http//www.marketsandmar
kets.com/Market-Reports/microbiology-testing-marke
t-219135367.html Blood Screening Market by
Technology (Nucleic Acid Amplification Test,
ELISA, Rapid Test, Chemiluminescence Immunoassay,
Next Generation Sequencing, Western Blotting),
Product (Instrument, Reagent) End User (Blood
Bank, Hospital) - Forecasts to 2019. http//www.ma
rketsandmarkets.com/Market-Reports/blood-screening
-market-267747042.html
7
About Report Publisher MarketsandMarkets is
the worlds No. 2 firm in terms of annually
published premium market research reports.
Serving 1700 global fortune enterprises with more
than 1200 premium studies in a year, MM is
catering to a multitude of clients across 8
different industrial verticals. We specialize in
consulting assignments and business research
across high growth markets, cutting edge
technologies and newer applications.
MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence
repository. Annual Market Research Reports
Subscription - http//www.marketsandmarkets.com/Su
bscription.html Contact Mr. Rohan Markets and
Markets UNIT no 802, Tower no. 7, SEZ Magarpatta
city, Hadapsar Pune, Maharashtra 411013,
India 1-888-600-6441